Baytril Flavour 15 mg tabl. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

baytril flavour 15 mg tabl.

bayer animal health gmbh - enrofloxacin 15 mg - tablet - 15 mg - enrofloxacin 15 mg - enrofloxacin - dog; cat

Enrox Flavour 15 mg tabl. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

enrox flavour 15 mg tabl.

krka d.d. novo mesto d.d. - enrofloxacin 15 mg - tablet - 15 mg - enrofloxacin 15 mg - enrofloxacin - dog; cat

Enroxal Flavour 15 mg tabl. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

enroxal flavour 15 mg tabl.

krka d.d. novo mesto d.d. - enrofloxacin 15 mg - tablet - 15 mg - enrofloxacin 15 mg - enrofloxacin - dog; cat

Floxabactin 15 mg tabl. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

floxabactin 15 mg tabl.

le vet pharma b.v. - enrofloxacin 15 mg - tablet - 15 mg - enrofloxacin 15 mg - enrofloxacin - dog; cat

Xeden 15 mg tabl. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

xeden 15 mg tabl.

ceva santé animale sa-nv - enrofloxacin 15 mg - tablet - 15 mg - enrofloxacin 15 mg - enrofloxacin - cat

Enrox Flavour 15 mg Tablets for dogs and cats Ireland - English - HPRA (Health Products Regulatory Authority)

enrox flavour 15 mg tablets for dogs and cats

krka, d.d., novo mesto - enrofloxacin - tablet - 15 mg/tablet - enrofloxacin - cats, dogs - antibacterial

ENROFLOXACIN FLAVORED- enrofloxacin tablet, chewable United States - English - NLM (National Library of Medicine)

enrofloxacin flavored- enrofloxacin tablet, chewable

putney, inc. - enrofloxacin (unii: 3dx3xek1bn) (enrofloxacin - unii:3dx3xek1bn) - enrofloxacin 22.7 mg - enrofloxacin flavored tablets are indicated for the management of diseases associated with bacteria susceptible to enrofloxacin. enrofloxacin flavored tablets are indicated for use in dogs and cats. enrofloxacin is contraindicated in dogs and cats known to be hypersensitive to quinolones. dogs: based on the studies discussed under the section on animal safety summary, the use of enrofloxacin is contraindicated in small and medium breeds of dogs during the rapid growth phase (between 2 and 8 months of age). the safe use of enrofloxacin has not been established in large and giant breeds during the rapid growth phase. large breeds may be in this phase for up to one year of age and the giant breeds for up to 18 months. in clinical field trials utilizing a daily oral dose of 5.0 mg/kg, there were no reports of lameness or joint problems in any breed. however, controlled studies with histological examination of the articular cartilage have not been conducted in the large or giant breeds.

Floxabactin 15 mg tablets for cats and dogs Ireland - English - HPRA (Health Products Regulatory Authority)

floxabactin 15 mg tablets for cats and dogs

le vet bv - enrofloxacin - tablet - 15 mg/tablet - enrofloxacin - cats, dogs - antibacterial

Baytril Flavour Tablets 15 mg Ireland - English - HPRA (Health Products Regulatory Authority)

baytril flavour tablets 15 mg

elanco gmbh - enrofloxacin - tablet - 15 mg/tablet - enrofloxacin

ENROFLOXACIN FLAVORED- enrofloxacin tablet United States - English - NLM (National Library of Medicine)

enrofloxacin flavored- enrofloxacin tablet

felix pharmaceuticals private limited - enrofloxacin (unii: 3dx3xek1bn) (enrofloxacin - unii:3dx3xek1bn) - enrofloxacin flavored tablets are indicated for the management of diseases associated with bacteria susceptible to enrofloxacin. enrofloxacin flavored tablets are indicated for use in dogs and cats. enrofloxacin is contraindicated in dogs and cats known to be hypersensitive to quinolones. dogs: based on the studies discussed under the section on animal safety summary, the use of enrofloxacin is contraindicated in small and medium breeds of dogs during the rapid growth phase (between 2 and 8 months of age). the safe use of enrofloxacin has not been established in large and giant breeds during the rapid growth phase. large breeds may be in this phase for up to one year of age and the giant breeds for up to 18 months. in clinical field trials utilizing a daily oral dose of 5.0 mg/kg, there were no reports of lameness or joint problems in any breed. however, controlled studies with histological examination of the articular cartilage have not been conducted in the large or giant breeds.